Time to open up the finances of medical journalsBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e4968 (Published 23 July 2012) Cite this as: BMJ 2012;345:e4968
- Richard Smith, chair1
- 1Patients Know Best, London SW4 0LD, UK
Perhaps the most striking thing about this paper is that the American publishers—all doctors’ organisations—refused to provide data. Inevitably, readers will wonder what they are hiding.1 The answer, I suspect, is the massive profits that they make from selling reprints of research funded by drug companies.
Around a half of drug sales are in North America, and reprints are …